Pharmerica (PMC) Tops Q1 EPS by 5c

Pharmerica (NYSE: PMC) reported Q1 EPS of $0.48, $0.05 better than the analyst estimate of $0.43. Revenue for the quarter came in at $511.6 million versus the consensus estimate of $500.95 million.

Pharmerica sees FY2015 EPS of $1.55-$1.65, versus the consensus of $1.62. Pharmerica sees FY2015 revenue of $1.95-2.05 billion, versus the consensus of $2.03 billion.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Netflix (NFLX) Tops Q2 EPS by 1c, Offers Guidance
• Washington Federal (WAFD) Misses Q3 EPS by 1c